CN101053593A - 胜红清热颗粒及其制备方法 - Google Patents
胜红清热颗粒及其制备方法 Download PDFInfo
- Publication number
- CN101053593A CN101053593A CN 200610018803 CN200610018803A CN101053593A CN 101053593 A CN101053593 A CN 101053593A CN 200610018803 CN200610018803 CN 200610018803 CN 200610018803 A CN200610018803 A CN 200610018803A CN 101053593 A CN101053593 A CN 101053593A
- Authority
- CN
- China
- Prior art keywords
- parts
- granule
- heat
- shenghong
- clearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims description 26
- 239000003814 drug Substances 0.000 claims abstract description 35
- 238000001694 spray drying Methods 0.000 claims abstract description 26
- 239000000341 volatile oil Substances 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920001353 Dextrin Polymers 0.000 claims abstract description 16
- 239000004375 Dextrin Substances 0.000 claims abstract description 16
- 235000019425 dextrin Nutrition 0.000 claims abstract description 16
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 14
- 229930006000 Sucrose Natural products 0.000 claims abstract description 14
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims description 32
- 244000104272 Bidens pilosa Species 0.000 claims description 18
- 235000010662 Bidens pilosa Nutrition 0.000 claims description 18
- 239000005720 sucrose Substances 0.000 claims description 12
- 239000007921 spray Substances 0.000 claims description 11
- 241000555712 Forsythia Species 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 229940079593 drug Drugs 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 16
- 239000006071 cream Substances 0.000 abstract description 10
- 239000000284 extract Substances 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 9
- 229960004793 sucrose Drugs 0.000 abstract 2
- 244000296912 Ageratum conyzoides Species 0.000 abstract 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 31
- 239000008280 blood Substances 0.000 description 31
- 239000000843 powder Substances 0.000 description 27
- 208000002193 Pain Diseases 0.000 description 20
- 238000005516 engineering process Methods 0.000 description 19
- 239000004615 ingredient Substances 0.000 description 16
- 238000011282 treatment Methods 0.000 description 15
- 239000012567 medical material Substances 0.000 description 13
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 12
- 239000002775 capsule Substances 0.000 description 12
- 230000009545 invasion Effects 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 10
- 239000004518 granules dosage form Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 206010013786 Dry skin Diseases 0.000 description 7
- 230000001684 chronic effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000857 drug effect Effects 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 206010044008 tonsillitis Diseases 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 230000006872 improvement Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 231100000111 LD50 Toxicity 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- -1 drying Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000009688 liquid atomisation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 231100000456 subacute toxicity Toxicity 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000007415 Anhedonia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010016100 Faeces discoloured Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940095686 granule product Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
体外抑菌试验杀灭百分率%(以同等剂量的试验药品放入同等量相同活性的下述细菌,试验条件常温常压下进行) | ||||
金黄色葡萄球菌 | 绿脓杆菌 | 溶血性乙型链球菌 | 大肠杆菌 | |
在先申请胜红清热胶囊 | 81.7% | 78.6% | 71.2% | 72.8% |
本发明的胜红清热颗粒 | 90.5% | 91.3% | 76.4% | 78.6% |
治疗盆腔炎200例 | 治疗卡他性扁桃体炎100例 | 急性单纯性咽炎100例 | |||||||
治愈率% | 显效率% | 总有效率% | 治愈率% | 显效率% | 总有效率% | 治愈率% | 显效率% | 总有效率% | |
在先申请胜红清热胶囊 | 68.7% | 15.2% | 97.9% | 25.0% | 58.9% | 83.9% | 47.7% | 38.8% | 86.5% |
本发明的胜红清热颗粒 | 77.5% | 16.1% | 98.1% | 35.5% | 59.2% | 84.2% | 58.5% | 39.3% | 87.2% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100188035A CN101053593B (zh) | 2006-04-14 | 2006-04-14 | 胜红清热颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100188035A CN101053593B (zh) | 2006-04-14 | 2006-04-14 | 胜红清热颗粒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101053593A true CN101053593A (zh) | 2007-10-17 |
CN101053593B CN101053593B (zh) | 2012-01-11 |
Family
ID=38793759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100188035A Expired - Fee Related CN101053593B (zh) | 2006-04-14 | 2006-04-14 | 胜红清热颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101053593B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638251A (zh) * | 2013-12-15 | 2014-03-19 | 郭淑宁 | 一种治疗急性放射性食管炎的中药组合物 |
CN108114086A (zh) * | 2017-12-04 | 2018-06-05 | 杨忠华 | 一种润喉片及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586585A (zh) * | 2004-07-16 | 2005-03-02 | 福州海王金象中药制药有限公司 | 胜红清热胶囊 |
CN1733078A (zh) * | 2005-08-17 | 2006-02-15 | 张力 | 胜红清热片及其制备方法 |
-
2006
- 2006-04-14 CN CN2006100188035A patent/CN101053593B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638251A (zh) * | 2013-12-15 | 2014-03-19 | 郭淑宁 | 一种治疗急性放射性食管炎的中药组合物 |
CN103638251B (zh) * | 2013-12-15 | 2016-02-17 | 郭淑宁 | 一种治疗急性放射性食管炎的中药组合物 |
CN108114086A (zh) * | 2017-12-04 | 2018-06-05 | 杨忠华 | 一种润喉片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101053593B (zh) | 2012-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101195008B (zh) | 一种治疗妇科疾病的黄蒲洁肤洗剂及其制备工艺 | |
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN101019948A (zh) | 治疗痤疮的中药复方制剂 | |
CN102861271A (zh) | 外用消炎止痒软膏制剂及其制备方法 | |
CN105560372A (zh) | 一种治疗鼻炎的中药喷雾剂及其制备方法 | |
CN102266474A (zh) | 银连解毒胶囊 | |
CN101053593B (zh) | 胜红清热颗粒及其制备方法 | |
CN1150927C (zh) | 一种治疗急慢性咽喉炎,扁桃体炎的药物及其生产方法 | |
CN1244353C (zh) | 治疗痤疮的药物及其制备方法 | |
CN105412415A (zh) | 祛痤疮的药物组合物 | |
CN102357147B (zh) | 一种消炎、止痛、抗病毒的中药组合物酊剂及其制备方法 | |
CN101461850B (zh) | 一种中药组合物在制备治疗痤疮药物中的应用 | |
CN1163116A (zh) | 复方余甘子保健药片及其制作工艺 | |
CN1219527C (zh) | 治疗痤疮的软膏及其制备方法 | |
CN101623411A (zh) | 一种抗菌消炎、清热解毒、化瘀止痛的中药 | |
CN110227109B (zh) | 一种用于猪慢性湿疹的组合物及其制备方法 | |
CN112494617B (zh) | 一种妇科抑菌的天然草本药物组方和制备方法 | |
CN106880758A (zh) | 一种用于外阴瘙痒和湿疹皮炎顽癣的中药制剂及制备方法 | |
CN108653460B (zh) | 一种治疗慢性荨麻疹的中药组合物及其制备方法 | |
CN106344459A (zh) | 一种丹参净油祛痘洗面奶及其制备方法 | |
CN108578549B (zh) | 治疗痤疮的药物及其应用 | |
CN100558376C (zh) | 辣乙素片剂及其制备工艺 | |
CN1058178C (zh) | 一种防治痤疮皮肤病的化妆品及其生产方法 | |
CN106727821A (zh) | 生物银纳米颗粒痔疮膏的制备方法 | |
CN100384447C (zh) | 一种治疗妇科疾病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAIWANG JINXIANG CHINESE MEDICINE PHARMACEUTICAL C Free format text: FORMER OWNER: XU YANHE Effective date: 20120813 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120813 Address after: Gushan Town Middle District Fuzhou Fujian province 350014 No. 278 Patentee after: FUZHOU NEPTUNUS JINXIANG TRADITIONAL CHINESE MEDICINE PHARMACEUTICAL CO.,LTD. Address before: Jinan District of Fuzhou City, Fujian province 350014 Kui Qi Patentee before: Xu Yanhe |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120111 |